Cargando…
Evidence-based clinical practice guidelines for inflammatory bowel disease
Inflammatory bowel disease (IBD) is a chronic disorder involving mainly the intestinal tract, but possibly other gastrointestinal and extraintestinal organs. Although etiology is still uncertain, recent knowledge in pathogenesis has accumulated, and novel diagnostic and therapeutic modalities have b...
Autores principales: | Matsuoka, Katsuyoshi, Kobayashi, Taku, Ueno, Fumiaki, Matsui, Toshiyuki, Hirai, Fumihito, Inoue, Nagamu, Kato, Jun, Kobayashi, Kenji, Kobayashi, Kiyonori, Koganei, Kazutaka, Kunisaki, Reiko, Motoya, Satoshi, Nagahori, Masakazu, Nakase, Hiroshi, Omata, Fumio, Saruta, Masayuki, Watanabe, Toshiaki, Tanaka, Toshiaki, Kanai, Takanori, Noguchi, Yoshinori, Takahashi, Ken-ichi, Watanabe, Kenji, Hibi, Toshifumi, Suzuki, Yasuo, Watanabe, Mamoru, Sugano, Kentaro, Shimosegawa, Tooru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Japan
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847182/ https://www.ncbi.nlm.nih.gov/pubmed/29429045 http://dx.doi.org/10.1007/s00535-018-1439-1 |
Ejemplares similares
-
The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet’s disease: indication of anti-TNFα monoclonal antibodies
por: Hisamatsu, Tadakazu, et al.
Publicado: (2013) -
Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet’s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants
por: Watanabe, Kenji, et al.
Publicado: (2020) -
Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study
por: Naganuma, Makoto, et al.
Publicado: (2017) -
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
por: Hibi, Toshifumi, et al.
Publicado: (2023) -
Evidence-based clinical practice guidelines for inflammatory bowel disease 2020
por: Nakase, Hiroshi, et al.
Publicado: (2021)